Tagged for success? Singapore start-up BioLynx hits the ground running
This article was originally published in Scrip
Executive Summary
A new bioventure spun off from research at the National University of Singapore is aiming to apply its tagging technology to a broad range of drugs to improve understanding of how they work at the cellular level, and is already set to launch its first product over the next few months.